The effects of opioids on perioperative outcomes in patients with obstructive sleep apnoea

Vladimir Macavei (London, United Kingdom), Vladimir Macavei, Maryiam Yasin, Adam Barnett, Terry O’Shaughnessy

Source: International Congress 2016 – Comorbid sleep apnoea in specific clinical entities and differential diagnosis of sleep disorders
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Vladimir Macavei (London, United Kingdom), Vladimir Macavei, Maryiam Yasin, Adam Barnett, Terry O’Shaughnessy. The effects of opioids on perioperative outcomes in patients with obstructive sleep apnoea. Eur Respir J 2016; 48: Suppl. 60, 2331

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prolonged symptoms and sleep quality after hospitalization for covid-19 in patients with obstructive sleep apnoea
Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing
Year: 2021



The influence of long-term CPAP therapy on metabolic variables in obstructive sleep apnea patients
Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Year: 2018


Functional effectiveness of auto-CPAP therapy in COPD patients with obstructive sleep apnea
Source: International Congress 2016 – Noninvasive ventilation and beyond: novelties and real-life applications
Year: 2016


Short- and long-term prevalence of complex sleep apnoea in patients treated for obstructive sleep apnoea
Source: Annual Congress 2009 - Complex sleep apnoea and adaptive servo ventilation
Year: 2009


Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Year: 2012


Long-term cardiovascular outcomes of patients with obstructive sleep apnoea not treated with nasal CPAP
Source: Eur Respir J 2002; 20: Suppl. 38, 294s
Year: 2002

Predictors of residual sleepiness in adequately treated obstructive sleep apnoea patients
Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea
Year: 2009


Impact of antihypertensive drugs on Watch-PAT variables in patients with obstructive sleep apnea.
Source: International Congress 2019 – Diagnostic issues in obstructive sleep apnoea
Year: 2019

Impact of sleep onset on hemodynamic parameters in obese patients with or without obstructive sleep apnea
Source: International Congress 2017 – New pathophysiological insights: intermittent hypoxia, cardiopulmonary function and biomarkers
Year: 2017


The use of beta-blockers is not associated with increased daytime sleepiness in patients with obstructive sleep apnoea
Source: International Congress 2019 – Beyond continuous positive airway pressure treatment
Year: 2019

Predicting outcome of nasal surgery in patients with obstructive sleep apnoea
Source: Eur Respir J 2008; 32: 246
Year: 2008


Pulse-rate variability during sleep studies predicts stroke risk in patients with obstructive sleep apnea
Source: Virtual Congress 2021 – From pathophysiology to different diagnostic modalities in sleep disordered breathing
Year: 2021



Cardiovascular and metabolic effects of CPAP in obese obstructive sleep apnoea patients
Source: Eur Respir J 2008; 31: 223-225
Year: 2008


Perioperative screening for obstructive sleep apnoea and treatment outcomes: where are the data?
Source: Eur Respir J 2016; 48: 21-22
Year: 2016


Determinants of CPAP compliance in bariatric patients with obstructive sleep apnoea
Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment
Year: 2017

Factors influencing efficacy of BiPAP therapy in severe obstructive sleep apnea
Source: Annual Congress 2013 –Sleep disordered breathing in special situations III
Year: 2013

Long-term efficacy of solriamfetol for excessive sleepiness in narcolepsy or obstructive sleep apnea
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019


Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea
Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing
Year: 2021


Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea
Source: Sleep and Breathing Conference 2021
Year: 2021



Predictors of long-term PAP-adherence in obstructive sleep apnea syndrome
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012